[HTML][HTML] Fungal vaccines, mechanism of actions and immunology: A comprehensive review

S Nami, R Mohammadi, M Vakili, K Khezripour… - Biomedicine & …, 2019 - Elsevier
Fungal infections include a wide range of opportunistic and invasive diseases. Two of four
major fatal diseases in patients with human immunodeficiency virus (HIV) infection are …

Paracoccidioidomycosis: eco-epidemiology, taxonomy and clinical and therapeutic issues

AL Bocca, AC Amaral, MM Teixeira, PK Sato… - Future …, 2013 - Taylor & Francis
Acquired by inhalation of the thermal dimorphic fungi Paracoccidioides spp. conidia,
paracoccidioidomycosis ranges from symptomatic to severe and potentially fatal …

Application of anti-fungal vaccines as a tool against emerging anti-fungal resistance

R Kumar, V Srivastava - Frontiers in Fungal Biology, 2023 - frontiersin.org
After viruses and bacteria, fungal infections remain a serious threat to the survival and well-
being of society. The continuous emergence of resistance against commonly used anti …

[HTML][HTML] New insights on the development of fungal vaccines: from immunity to recent challenges

NP Medici, M Del Poeta - Memórias do Instituto Oswaldo Cruz, 2015 - SciELO Brasil
Fungal infections are emerging as a major problem in part due to high mortality associated
with systemic infections, especially in the case of immunocompromised patients. With the …

Fungal vaccine development: State of the art and perspectives using Immunoinformatics

MM Inácio, ALE Moreira, VRM Cruz-Leite, K Mattos… - Journal of Fungi, 2023 - mdpi.com
Fungal infections represent a serious global health problem, causing damage to health and
the economy on the scale of millions. Although vaccines are the most effective therapeutic …

Advances in fungal peptide vaccines

L BR Da Silva, C P. Taborda, J D. Nosanchuk - Journal of fungi, 2020 - mdpi.com
Vaccination is one of the greatest public health achievements in the past century, protecting
and improving the quality of life of the population worldwide. However, a safe and effective …

Paracoccidioidomycosis: challenges in the development of a vaccine against an endemic mycosis in the Americas

CP Taborda, ME Urán, JD Nosanchuk… - Revista do Instituto de …, 2015 - SciELO Brasil
Paracoccidioidomycosis (PCM), caused by Paracoccidioides spp, is an important endemic
mycosis in Latin America. There are two recognized Paracoccidioides species, P …

Miltefosine is fungicidal to Paracoccidioides spp. yeast cells but subinhibitory concentrations induce melanisation

DCP Rossi, C de Castro Spadari, JD Nosanchuk… - International journal of …, 2017 - Elsevier
Paracoccidioidomycosis (PCM) is a systemic mycosis caused by the dimorphic fungi
Paracoccidioides spp. The duration of antifungal treatment ranges from months to years and …

Vaccine development for pathogenic fungi: current status and future directions

JL Chechi, FAC da Costa, JM Figueiredo… - Expert Review of …, 2023 - Taylor & Francis
Introduction Fungal infections are caused by a broad range of pathogenic fungi that are
found worldwide with different geographic distributions, incidences, and mortality rates …

Recent advances in the clinical development of antifungal vaccines: a narrative review

D Alapan, O Bisweswar, S Prasenjit… - Frontiers in Tropical …, 2024 - frontiersin.org
Vaccine development tools for fungal infections are undergoing transformation where newer
technologies like nanotechnology and bioinformatics are used to create new and improved …